Innoviva

Recent news

• Rating change
  Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA)
  TipRanks · 2026/5/27
• Rating change
  Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $32
  Market Newswire · 2026/2/26
• H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $46
  Market Newswire · 2026/8/10
• Rating change
  Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $32
  Market Newswire · 2026/4/8
• Rating change
  TR | OpenAI - 4o Maintains Innoviva(INVA.US) With Hold Rating, Raises Target Price to $21.5
  Market Newswire · 2025/8/12
• Rating change
  H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $46
  Market Newswire · 2025/12/16
• Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $34
  Market Newswire · 2026/8/21
• Company notice
  Tianlong Group: Legal opinion of Beijing Guofeng Law Firm on the fulfillment of vesting conditions for some of the first vesting period in the second phase of the restricted stock incentive plan of Guangdong Tianlong Technology Group Co., Ltd. and the inva
  SZSI · 2022/8/16
• Rating change
  H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $45
  Market Newswire · 2025/12/12
• Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $34
  Market Newswire · 2026/8/7
• Rating change
  H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $45
  Market Newswire · 2025/8/11
• BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42
  Market Newswire · 2026/8/6
• Rating change
  Oppenheimer Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $35
  Market Newswire · 2025/8/11
• Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $119.6M, Vs. FactSet Est of $111.0M
  MT Newswires · 2026/8/6
• Rating change
  Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $31
  Market Newswire · 2025/12/15
• Rating change
  Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $31
  Market Newswire · 2025/11/6
• Rating change
  Oppenheimer Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $35
  Market Newswire · 2026/2/26
• Rating change
  BTIG Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $35
  Market Newswire · 2026/2/17
• Rating change
  BTIG Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $42
  Market Newswire · 2026/5/7
• Rating change
  Goldman Sachs Maintains Innoviva(INVA.US) With Sell Rating, Raises Target Price to $18
  Market Newswire · 2026/5/7

Headlines are aggregated automatically and are not independently verified or edited by our team.